Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Linda Vidarsdottir

Showing results (1-10 of 13) with videos related to

Pageof 2
Sort By:
Methods in Molecular Biology (Clifton, N.J.)|August 15, 2019
Designing siRNA and Evaluating Its Effect on RNA Targets Using qPCR and Western BlotLinda Vidarsdottir, Oksana Goroshchuk, Iryna Kolosenko, et al.
Oncogene|August 15, 2018
Polo-like kinases and acute leukemiaOksana Goroshchuk, Iryna Kolosenko, Linda Vidarsdottir, et al.
Cancer Letters|November 23, 2006
Breast cancer risk associated with AURKA 91T -->A polymorphism in relation to BRCA mutationsLinda Vidarsdottir, Sigridur K Bodvarsdottir, Holmfridur Hilmarsdottir, et al.
Investigational New Drugs|October 21, 2010
Sensitivity of BRCA2 mutated human cell lines to Aurora kinase inhibitionLinda Vidarsdottir, Gudridur Steingrimsdottir, Sigridur Klara Bodvarsdottir, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|March 31, 2021
RNAi prodrugs decrease elevated mRNA levels of Polo-like kinase 1 in ex vivo cultured primary cells from pediatric acute myeloid leukemia patientsIryna Kolosenko, Oksana Goroshchuk, Linda Vidarsdottir, et al.
Nature Structural & Molecular Biology|February 26, 2013
A pseudogene long-noncoding-RNA network regulates PTEN transcription and translation in human cellsPer Johnsson, Amanda Ackley, Linda Vidarsdottir, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|June 18, 2021
Thermal proteome profiling identifies PIP4K2A and ZADH2 as off-targets of Polo-like kinase 1 inhibitor volasertibOksana Goroshchuk, Iryna Kolosenko, Elena Kunold, et al.
NPJ Breast Cancer|November 30, 2023
Estrogen receptor-positive breast cancer and adverse outcome in BRCA2 mutation carriers and young non-carrier patientsLinda Vidarsdottir, Elinborg J Olafsdottir, Rosa B Barkardottir, et al.
Scientific Reports|February 16, 2020
Targeting Plk1 with siRNNs in primary cells from pediatric B-cell acute lymphoblastic leukemia patientsOksana Goroshchuk, Linda Vidarsdottir, Ann-Charlotte Björklund, et al.
Breast Cancer : Basic and Clinical Research|March 20, 2024
MicroRNA-190b Targets RFWD3 in Estrogen Receptor-Positive Breast CancerElisabet Alexandra Frick, Karen Kristjansdottir, Snaedís Ragnarsdottir, et al.
Pageof 2

Showing results (1-10 of 13) with videos related to

Sort By:
Pageof 2
Methods in Molecular Biology (Clifton, N.J.)|August 15, 2019
Designing siRNA and Evaluating Its Effect on RNA Targets Using qPCR and Western BlotLinda Vidarsdottir, Oksana Goroshchuk, Iryna Kolosenko, et al.
Oncogene|August 15, 2018
Polo-like kinases and acute leukemiaOksana Goroshchuk, Iryna Kolosenko, Linda Vidarsdottir, et al.
Cancer Letters|November 23, 2006
Breast cancer risk associated with AURKA 91T -->A polymorphism in relation to BRCA mutationsLinda Vidarsdottir, Sigridur K Bodvarsdottir, Holmfridur Hilmarsdottir, et al.
Investigational New Drugs|October 21, 2010
Sensitivity of BRCA2 mutated human cell lines to Aurora kinase inhibitionLinda Vidarsdottir, Gudridur Steingrimsdottir, Sigridur Klara Bodvarsdottir, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|March 31, 2021
RNAi prodrugs decrease elevated mRNA levels of Polo-like kinase 1 in ex vivo cultured primary cells from pediatric acute myeloid leukemia patientsIryna Kolosenko, Oksana Goroshchuk, Linda Vidarsdottir, et al.
Nature Structural & Molecular Biology|February 26, 2013
A pseudogene long-noncoding-RNA network regulates PTEN transcription and translation in human cellsPer Johnsson, Amanda Ackley, Linda Vidarsdottir, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|June 18, 2021
Thermal proteome profiling identifies PIP4K2A and ZADH2 as off-targets of Polo-like kinase 1 inhibitor volasertibOksana Goroshchuk, Iryna Kolosenko, Elena Kunold, et al.
NPJ Breast Cancer|November 30, 2023
Estrogen receptor-positive breast cancer and adverse outcome in BRCA2 mutation carriers and young non-carrier patientsLinda Vidarsdottir, Elinborg J Olafsdottir, Rosa B Barkardottir, et al.
Scientific Reports|February 16, 2020
Targeting Plk1 with siRNNs in primary cells from pediatric B-cell acute lymphoblastic leukemia patientsOksana Goroshchuk, Linda Vidarsdottir, Ann-Charlotte Björklund, et al.
Breast Cancer : Basic and Clinical Research|March 20, 2024
MicroRNA-190b Targets RFWD3 in Estrogen Receptor-Positive Breast CancerElisabet Alexandra Frick, Karen Kristjansdottir, Snaedís Ragnarsdottir, et al.
Pageof 2